Pancreatic Cancer Trial, Recruiting NCT07030348 Sponsor: Do Hyun Park Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07030348
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has two groups. People may be considered for the pancreatic cancer group if they meet all of the following:

  • The person is at least 19 years old.
  • The person has already signed informed consent for a planned upper endoscopy, endoscopic ultrasound, or ERCP procedure before any fluid collection takes place.
  • The person has a confirmed diagnosis of pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer) at any stage (I through IV), proven by biopsy — or — the person has imaging that suggests pancreatic cancer and is already scheduled for an endoscopic ultrasound-guided biopsy to investigate further.

People may be considered for the non-pancreatic cancer group if they meet all of the following:

  • The person is at least 19 years old.
  • The person has already signed informed consent for a planned upper endoscopy, endoscopic ultrasound, or ERCP procedure before any fluid collection takes place.
  • The person has a pancreatic cyst, or has been diagnosed with acute or chronic pancreatitis — or — the person has no known pancreatic disease.

Who may not be able to join:

  • The person has a natural or surgically altered body structure that would prevent direct collection of fluid from the duodenum (the first part of the small intestine).
  • The person is medically unstable in a way that makes it unsafe to perform an endoscopy.
  • The person has a large amount of uncontrolled fluid build-up in the abdomen that makes it unsafe to perform an endoscopy.
  • The person has a blood clotting disorder that cannot be corrected and that makes it unsafe to perform an endoscopy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82-2-2045-3825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Do Hyun Park
Registry
ClinicalTrials.gov
Start date
2 January 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇰🇷 South Korea 🇺🇸 United States

Primary endpoints

Identification of Biomarkers for Early Pancreatic Cancer Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov